<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
x

Microbiota Dynamically Facilitate Anti-PD-L1 Efficacy

Cancer immunotherapies such as antibodies targeting programmed death-ligand 1 (PD-L1), a checkpoint inhibitor, have achieved great success in treating a variety of cancer types.